Subspecialty Ambulatory Quality Cardiology Program | NCT07283666

Studies
Subspecialty Ambulatory Quality Cardiology Program

NCT07283666

Sponsor

NYU Langone Health

Status

Enrolling by invitation

Last Update Posted

Dec 16, 2025Actual

Enrollment

7,000Estimated

Phase

Not provided

Conditions

Heart Failure With Reduced Ejection Fraction
Atrial Fibrillation

Interventions

Not provided

Countries

United States

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Dec 2025

Overall Recruitment Status or Expanded Access Status

Enrolling by invitation

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Dec 19, 2024Actual

Primary Completion Date

Apr 1, 2026Estimated

Completion Date

Jul 1, 2026Estimated

First Submitted Date

Dec 4, 2025

First Submission Date that Met QC Criteria

Dec 4, 2025

First Posted Date

Dec 16, 2025Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Dec 4, 2025

Last Update Posted Date

Dec 16, 2025Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Investigators will evaluate the effectiveness of an audit and feedback performance improvement strategy in which cardiology providers receive quarterly emails on ambulatory quality improvement goals.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

7,000Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Quarterly Emails		Quarterly emails on performance will be sent.
Control		Usual Care (no emails on performance).

Interventions

Not provided

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Percentage of patients eligible for medications who are prescribed these medications		Day 1

Secondary Outcomes

Measure	Description	Time Frame
Percentage of patients with HFrEF prescribed aldosterone antagonists		Day 1
Percentage of patients with Afib prescribed oral anticoagulants		Day 1

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria for atrial fibrillation quality metric:

Active diagnosis of atrial fibrillation
CHADS2VASC of at least 2 in males and at least 3 in females
Outpatient cardiology visit in past 3 months

Inclusion Criteria for HFrEF quality metric:

Most recent EF ≤40
Age 18-90
Outpatient cardiology visit in past 3 months

Exclusion Criteria for atrial fibrillation quality metric:

LAAO device
Hemorrhagic Stroke

Exclusion Criteria for HFrEF quality metric:

SBP<90
eGFR<30
Potassium>5
Active allergy to MRA
Acknowledge reason on heart failure alert
Mechanical circulatory device
Cardiac amyloid diagnosis

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

90 Years

Standard Ages

AdultOlder Adult

Study Population

Patients seen by a cardiology provider in the ambulatory setting.

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Amrita Mukhopadhyay, MD	NYU Langone Health	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
NYU Langone Health		New York	New York	10016	United States

IPD Sharing Statement Module

Plan to Share IPD

Description

This is a quality improvement (QI) project and individual participant data (IPD) will not be shared with other researchers.

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D001281	Atrial Fibrillation

Ancestor Terms

ID	Term
D001145	Arrhythmias, Cardiac
D006331	Heart Diseases
D002318	Cardiovascular Diseases
D010335	Pathologic Processes

Browse Leaves

Not provided

Browse Branches

Not provided